We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
-9.07%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$178M
AUM Growth
-$77.9M
(-30%)
Cap. Flow
-$57.1M
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
66.72%
Holding
227
New
12
Increased
150
Reduced
51
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Syntax Stratified LargeCap ETF
SSPY
|
+$10.4M |
| 2 |
SMDY
Syntax Stratified MidCap ETF
SMDY
|
+$1.35M |
| 3 |
SSLY
Syntax Stratified SmallCap ETF
SSLY
|
+$724K |
| 4 |
Keurig Dr Pepper
KDP
|
+$261K |
| 5 |
Warner Bros
WBD
|
+$255K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$68.7M |
| 2 |
ADC Therapeutics
ADCT
|
+$4.67M |
| 3 |
NXP Semiconductors
NXPI
|
+$270K |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$257K |
| 5 |
Booking.com
BKNG
|
+$247K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.44% |
| 2 | Technology | 6.76% |
| 3 | Consumer Staples | 6.63% |
| 4 | Consumer Discretionary | 5.1% |
| 5 | Utilities | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Newell Brands
NWL
$2.38B
| $191K | 0.11% |
+10,020
| New | +$213K |
|
|
202
Warner Bros
WBD
$65.9B
| $184K | 0.1% |
+13,739
| New | +$255K |
|
203
American Airlines Group
AAL
$10.1B
| $132K | 0.07% |
10,415
-24
| -0.2% | -$400 |
|
204
WisdomTree
WT
$2.96B
| $76K | 0.04% |
14,927
+190
| +1% | +$1.09K |
|
|
TUP
205
DELISTED
Tupperware Brands Corporation
TUP
| $72K | 0.04% |
+11,416
| New | +$127K |
|
206
Sabre
SABR
$731M
| $64K | 0.04% |
+11,059
| New | +$92.4K |
|
|
DHC
207
Diversified Healthcare Trust
DHC
$2.15B
| $63K | 0.04% |
34,491
+8,960
| +35% | +$20.5K |
|
208
8x8 Inc
EGHT
$269M
| $56K | 0.03% |
+10,951
| New | +$91.7K |
|
209
Organogenesis Holdings
ORGO
$305M
| $51K | 0.03% |
+10,522
| New | +$64.8K |
|
210
Genworth Financial
GNW
$3.76B
| $48K | 0.03% |
13,472
-2,000
| -13% | -$7.65K |
|
211
Community Health Systems
CYH
$393M
| $42K | 0.02% |
+11,131
| New | +$78.4K |
|
212
Nektar Therapeutics
NKTR
$2.39B
| $41K | 0.02% |
+712
| New | +$44.9K |
|
|
DBD
213
DELISTED
Diebold Nixdorf Incorporated
DBD
| $40K | 0.02% |
+17,818
| New | +$66.4K |
|
|
214
Booking.com
BKNG
$149B
| – | – |
-2,625
| Closed | -$247K |
|
215
Barnes & Noble Education
BNED
$431M
| – | – |
-118
| Closed | -$42K |
|
216
Cintas
CTAS
$81.9B
| – | – |
-1,976
| Closed | -$210K |
|
|
CTRA
217
DELISTED
Coterra Energy
CTRA
| – | – |
-9,514
| Closed | -$257K |
|
218
Walt Disney
DIS
$167B
| – | – |
-1,479
| Closed | -$203K |
|
219
Devon Energy
DVN
$52.1B
| – | – |
-4,159
| Closed | -$246K |
|
220
Expedia Group
EXPE
$35.4B
| – | – |
-1,207
| Closed | -$236K |
|
221
F5
FFIV
$22.9B
| – | – |
-1,003
| Closed | -$210K |
|
222
Henry Schein
HSIC
$9.77B
| – | – |
-2,317
| Closed | -$202K |
|
|
223
NXP Semiconductors
NXPI
$57.8B
| – | – |
-1,457
| Closed | -$270K |
|
|
PARA
224
DELISTED
Paramount Global Class B
PARA
| – | – |
-5,980
| Closed | -$226K |
|
|
ZYXI
225
DELISTED
Zynex
ZYXI
| – | – |
-11,029
| Closed | -$69K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q2 2022 Portfolio in Review
As of Q2 2022, Vantage Consulting Group held 227 positions worth $178M, down 30% from $256M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Vantage Consulting Group withdrew a net $57.1M in Q2 2022, closing 14 positions and reducing 51 holdings. Its most notable exit was NXP Semiconductors, an estimated $270K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 57% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Vantage Consulting Group opened a new position in Keurig Dr Pepper worth $255K.
- Vantage Consulting Group's largest Q2 2022 buy was Keurig Dr Pepper: 7,196 shares worth $255K.
- Vantage Consulting Group added most to Syntax Stratified LargeCap ETF in Q2 2022, an estimated $10.4M increase.
- Vantage Consulting Group's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $68.7M.
- Vantage Consulting Group fully exited NXP Semiconductors in Q2 2022, selling an estimated $270K.
- Vantage Consulting Group's ten largest holdings make up 67% of its $178M portfolio in Q2 2022.
- Vantage Consulting Group opened 12 new positions and closed 14 in Q2 2022.
- Vantage Consulting Group's portfolio value fell 30% quarter-over-quarter to $178M.
Based on Vantage Consulting Group's 13F filing for Q2 2022, filed 9 Aug 2022.